Novoheart Holdings Inc. is pleased to announce that the previously announced acquisition by Novomed Limited of all the issued and outstanding common shares of Novoheart other than those Novoheart Shares already owned by certain beneficial owners of Novomed, by way of a plan of arrangement under the Business Corporations Act (British Columbia) has been completed.

Novoheart Holdings Inc. announces that it has entered into a definitive arrangement agreement with a purchaser to acquire all of the issued and outstanding common shares of Novoheart, other than those Novoheart Shares currently owned by certain shareholders who have entered into rollover, voting and support agreements with the purchase, for cash consideration of C$0.53 per Novoheart Share by way of a statutory plan of arrangement under the Business Corporations Act (British Columbia).

Novoheart Holdings Inc.reports financial results for the three months ended June 30, 2019. Amounts, unless specified otherwise, are expressed in Canadian dollars and are in accordance with International Financial Reporting Standards (IFRS).

Novoheart Holdings Inc.reports financial results for the three months ended March 31, 2019. Amounts, unless specified otherwise, are expressed in Canadian dollars and are in accordance with International Financial Reporting Standards (IFRS).